162 related articles for article (PubMed ID: 10403466)
1. The role of taxanes in the management of breast cancer.
Nabholtz JM
Semin Oncol; 1999 Jun; 26(3 Suppl 8):1-3. PubMed ID: 10403466
[No Abstract] [Full Text] [Related]
2. Docetaxel (Taxotere) for advanced breast cancer.
Med Lett Drugs Ther; 1996 Sep; 38(984):87-8. PubMed ID: 8828520
[No Abstract] [Full Text] [Related]
3. Taxanes in the treatment of early breast cancer.
Ring AE; Ellis PA
Cancer Treat Rev; 2005 Dec; 31(8):618-27. PubMed ID: 16266787
[TBL] [Abstract][Full Text] [Related]
4. Introduction: taxoids and the management of breast cancer.
Hortobagyi GN
Semin Oncol; 1997 Aug; 24(4 Suppl 13):S13-1-S13-2. PubMed ID: 9335510
[No Abstract] [Full Text] [Related]
5. Taxanes in the treatment of breast cancer: a prodigy comes of age.
Miller KD; Sledge GW
Cancer Invest; 1999; 17(2):121-36. PubMed ID: 10071597
[TBL] [Abstract][Full Text] [Related]
6. Use of taxanes in the treatment of patients with breast cancer has increased dramatically over the past 8 years.
Partridge A; Winer E
Clin Breast Cancer; 2000 Jul; 1(2):164-5. PubMed ID: 11899655
[No Abstract] [Full Text] [Related]
7. The clinical rationale for developing docetaxel (Taxotere).
Armand JP
Anticancer Drugs; 1996 Aug; 7 Suppl 2():37-9. PubMed ID: 8862710
[TBL] [Abstract][Full Text] [Related]
8. Review of recent trials of chemotherapy for advanced breast cancer: the taxanes.
Clemons M; Leahy M; Valle J; Jayson G; Ranson M; Howell A
Eur J Cancer; 1997 Nov; 33(13):2183-93. PubMed ID: 9470804
[No Abstract] [Full Text] [Related]
9. [Taxanes: a breakthrough in cancer chemotherapy].
Inbar M; Merimsky O; Chaitchik S
Harefuah; 1997 Jul; 133(1-2):31-6. PubMed ID: 9332055
[No Abstract] [Full Text] [Related]
10. Taxoids: effective agents in anthracycline-resistant breast cancer.
Ravdin PM
Semin Oncol; 1995 Dec; 22(6 Suppl 13):29-34. PubMed ID: 8604450
[TBL] [Abstract][Full Text] [Related]
11. Taxotere shows significant antitumor activity in anthracycline-resistant breast cancer patients.
Oncology (Williston Park); 1994 Sep; 8(9):112. PubMed ID: 7993720
[No Abstract] [Full Text] [Related]
12. The role of taxanes as a component of neoadjuvant chemotherapy for breast cancer.
Gogas H; Fountzilas G
Ann Oncol; 2003 May; 14(5):667-74. PubMed ID: 12702519
[No Abstract] [Full Text] [Related]
13. Emerging role of docetaxel (Taxotere) in the adjuvant therapy of breast cancer.
Ravdin PM
Semin Oncol; 1999 Jun; 26(3 Suppl 9):20-3. PubMed ID: 10426455
[TBL] [Abstract][Full Text] [Related]
14. [Taxenes: a new hope of clinical oncology in the 90-ies].
Shparik IV
Vopr Onkol; 1995; 41(1):7-12. PubMed ID: 7667946
[No Abstract] [Full Text] [Related]
15. Docetaxel and paclitaxel in breast cancer therapy: present status and future prospects.
D'Andrea GM; Seidman AD
Semin Oncol; 1997 Aug; 24(4 Suppl 13):S13-27-S13-44. PubMed ID: 9335514
[TBL] [Abstract][Full Text] [Related]
16. Docetaxel improves survival and reduces risk of relapse in node-positive early-stage breast cancer.
Expert Rev Anticancer Ther; 2002 Jun; 2(3):242-3. PubMed ID: 12113040
[No Abstract] [Full Text] [Related]
17. Paclitaxel and docetaxel in breast and ovarian cancer.
Drug Ther Bull; 1997 Jun; 35(6):43-6. PubMed ID: 9282422
[TBL] [Abstract][Full Text] [Related]
18. An expanding role for docetaxel.
Hortobagyi G
Semin Oncol; 1998 Dec; 25(6 Suppl 13):1-3. PubMed ID: 9865684
[No Abstract] [Full Text] [Related]
19. Taxanes in paediatric oncology: and now?
André N; Meille C
Cancer Treat Rev; 2006 Apr; 32(2):65-73. PubMed ID: 16497442
[TBL] [Abstract][Full Text] [Related]
20. Management of advanced breast cancer: patient needs, challenges and new treatment options. Introduction.
Norton L
Anticancer Drugs; 1996 Aug; 7 Suppl 2():1-3. PubMed ID: 8862701
[No Abstract] [Full Text] [Related]
[Next] [New Search]